Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Note 8 - Deferred Revenue (Details) (USD $)			1 Months Ended
Note 8 - Deferred Revenue (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2004 JNJ Agreement [Member] Ortho Biotech Products, L.P. [Member]	Feb. 28, 2004 JNJ Agreement [Member] Ortho Biotech Products, L.P. [Member]	Dec. 31, 2003 JNJ Agreement [Member] Ortho Biotech Products, L.P. [Member]	Dec. 31, 2011 Mitek MONOVISC Agreement [Member] DePuy Mitek, Inc.[Member]
Note 8 - Deferred Revenue (Details) [Line Items]
Licensing and supply agreement term					10 years	15 years
Proceeds from Initial Payment on Licensing and Supply Agreement					$ 2,000,000	$ 2,500,000
Proceeds from Milestone Payments			5,000,000	20,000,000
Deferred Revenue	$ 2,235,374	$ 5,027,845